Table 3.
Protein description | Accession no. | Relative emPAI (%)b |
Gammaherpesvirinae |
Alphaherpesvirinae |
Beta- |
|||||
---|---|---|---|---|---|---|---|---|---|---|
CTRL | pK | Rhadinoviruses |
Maca- |
Lymph- |
Simpl- |
Varicel- |
Cyto- |
|||
KSHV | MuHV-4 | AlHV-1 | EBV | HSV-1 | PRV | HCMV | ||||
Signaling | ||||||||||
14-3-3 protein theta | gi¦5803227 | 0.25 | 0.07 | + | + | |||||
14-3-3 protein gamma | gi¦9507245 | 0.25 | 0.07 | + | + | |||||
Cytoskeleton | ||||||||||
Profilin-1 | gi¦62751593 | 1.11 | 0.14 | + | ||||||
Ezrin | gi¦27806351 | 0.70 | 0.03 | + | ||||||
Actin | gi¦4501885 | 4.30 | 0.61 | + | + | + | + | + | + | |
KRT18 protein | gi¦148878161 | 0.47 | 0.08 | + | ||||||
Cofilin-1 | gi¦51592135 | 2.10 | 1.11 | + | + | + | ||||
mRNA binding and processing | ||||||||||
Elongation factor 1-alpha 1 | gi¦4503471 | 0.45 | 0.13 | + | + | |||||
Membrane organization and trafficking | ||||||||||
Annexin 1 | gi¦74 | 0.83 | 0.31 | + | + | + | + | |||
Annexin 2 | gi¦27807289 | 6.40 | 2.04 | + | + | + | + | + | ||
Metabolism | ||||||||||
Triosephosphate isomerase | gi¦61888856 | 0.57 | 0.26 | + | + | |||||
Bov mitochondrial F1-ATPase (A) | gi¦1827809 | 1.10 | 0.08 | |||||||
Chain B, Bov cytochrome Bc1 | gi¦3891849 | 0.15 | 0.04 | |||||||
Ion channel | ||||||||||
Chloride intracellular channel 1 | gi¦62751970 | 0.57 | 0.16 | |||||||
Phosphate carrier protein | gi¦27807185 | 0.17 | 0.05 |
Abbreviations: Beta-, Betaherpesvirinae; Maca-, macaviruses; Lymph-, lymphocryptoviruses; Simpl-, simplexviruses; Varicel-, varicelloviruses; Cyto-, cytomegaloviruses; Bov, bovine.
Relative emPAI values were calculated as the emPAI values calculated for each analysis relative to the abundance of pORF52 taken as 100%. Values > 0.5 are highlighted in boldface. CTRL, values obtained with virion-enriched preparations analyzed by the 1D gel/nano-LC-MS/MS procedure. pK, values obtained with virion-enriched preparations (same as in CTRL) analyzed by the 1D gel/nano-LC-MS/MS procedure after proteinase K treatment. Data indicated for Gammaherpesvirinae, Alphaherpesvirinae, and Betaherpesvirinae are based on previously published studies (2, 3, 5, 8, 17, 20, 23, 30, 42, 45).